Cramer's Lightning Round - I Can't Get My Arms Around The New Kodak (1/10/14)

by: Miriam Metzinger

Stocks discussed on the Lightning Round segment of Jim Cramer's Mad Money Program, Monday January 10.

Bullish Calls:

Gilead (NASDAQ:GILD), Regeneron (NASDAQ:REGN), Celgene (NASDAQ:CELG), Biogen Idec (NASDAQ:BIIB): These are biotechs Cramer prefers to Amgen.

Isis Pharmaceuticals (ISIS): "I continue to like it. It has moved up a great deal, but I think it is good."

Intel (NASDAQ:INTC): "It is good, cheaper (than Advanced MicroDevices) and is out of favor."

Neutral Call:

Eastman Kodak (NYSE:KODK): "We took a look at it. I couldn't get my arms around the new Kodak, but I would invite them on the show."

Bearish Calls:

Amgen (NASDAQ:AMGN): "It is one of my least favorite biotechs. They made an acquisition that put it in competition with Celgene. I prefer Celgene, Gilead, Biogen Idec and Regeneron."

Advanced MicroDevices (NYSE:AMD): "AMD has had a history of missing quarters. I would sell this stock and buy Intel ... "

Haliburton (NYSE:HAL): "It is one of the weaker companies. If you like it, wait until Schlumberger speaks (on its earnings) on Friday ... Wait to see what they say. Be very careful."

Xoma (NASDAQ:XOMA): "It is too hot. It has moved too much."


Jim Cramer’s Action Alerts PLUS: Check out Cramer’s multi-million dollar charitable trust portfolio and uncover the stocks he thinks could be HUGE winners. Start your FREE 14-day trial now!

Get Cramer's Picks by email - it's free and takes only a few seconds to sign up.